# Safety and Tolerability of PNT001 in Healthy Adults

> **NCT04096287** · PHASE1 · COMPLETED · sponsor: **Pinteon Therapeutics, Inc** · enrollment: 49 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** PNT001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04096287
- **Lead sponsor:** Pinteon Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-17
- **Primary completion:** 2021-02-15
- **Final completion:** 2021-02-15
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2021-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096287, "Safety and Tolerability of PNT001 in Healthy Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04096287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*